Latest Breaking News On - Jianguo ma - Page 1 : vimarsana.com

Viva Biotech s Recent Conferences & Events Review

/PRNewswire/ In April, Viva Biotech was invited to attend 2022 SAPA-China Annual Conference, 88th API China, Drug Discovery Chemistry, American Association.

United statesSan diegoYinghong gaoMaarten postemaJianhua caiOhan daiRajeev hotchandaniJianguo maViva bioinnovatorDevelopment of china biopharmaceutical industryLanghua pharmaceuticalsInternational gene festivalAmerican association for cancer researchSmall molecule drug developmentAmerican pharmaceutical professionals associationYangzhou biopharmaceutical forum

Viva Biotech Attended SAPA-China

/PRNewswire/ 6th-7th April, the "2022 SAPA-China Annual Conference - Opportunities and Challenges for the Development of China s Biopharmaceutical Industry".

United statesJianguo maJianhua caiZenon konteatisAmerican pharmaceutical professionals associationViva biotech holdingsDevelopment of china biopharmaceutical industryChina annual conferenceViva biotechSenior vice presidentLanghua pharmaceuticalMedicinal chemistry

Viva Biotech Successfully Held 2021 Partnership Summit -- Novel Drug 2021, the Persistence and Transformation of Start-up Founders

nd-6 th, 2021, Viva Biotech successfully hosted the 2021 Partnership Summit. Over 300 attendees joined the Summit, including representatives from global investment institutions, R&D heads from pharmaceutical companies, and business development leaders. As one of the largest annual events held by Viva, the Partnership Summit is committed to gathering the leading forces from the scientific research community, bio pharmaceutical industry, capital groups and more to assist biotech start-ups in achieving development success and commercialization. Viva Biotech 2021 Partnership Summit For the opening speech of the Summit, Dr. David Xu, CBO of Viva Biotech, gave an overview of Viva BioInnovator s (VBI) development and achievements to the more than 60 founders in attendance during the Executive Day. Along with the continuous expansion of Viva s technology platforms, VBI will continue to optimize their capabilities in multiple dimensions such as CRO services, cooperative ecosystems, and o

Al iskandariyahSisu pharmaBrian hubbardHwang shenViva bioinnovatorForkhead biotherapeuticsDtx pharmaSam cooperDerek renShunqi yanQiyuan bioDan meyersKasper roetArthur suckcowVincere biosciencesHuang qing

Viva Biotech Successfully Held 2021 Partnership Summit -- Novel Drug 2021, the Persistence and Transformation of Start-up Founders

Viva Biotech Successfully Held 2021 Partnership Summit -- Novel Drug 2021, the Persistence and Transformation of Start-up Founders
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

Al iskandariyahSisu pharmaBrian hubbardHwang shenViva bioinnovatorForkhead biotherapeuticsDtx pharmaSam cooperDerek renShunqi yanQiyuan bioDan meyersKasper roetArthur suckcowVincere biosciencesHuang qing

Accelerating Innovation, Deepening Integration | Viva Biotech Online Investor Day Review

Search jobs Accelerating Innovation, Deepening Integration | Viva Biotech Online Investor Day Review SHANGHAI, Dec. 13, 2020 /PRNewswire/ Viva Biotech s Online Investor Day was successfully hosted on December 8, 2020. The management team conducted an online dialogue with nearly 400 investors, focusing on the company s strategy, personnel plans, technology platforms, integration strategic plans, investment incubation, and more. Dr. Chen Mao, Chairman and CEO of Viva Biotech, shared the market potential for CRO and CDMO companies, as well as the four major trends of the CXO industry. Dr. Mao also elaborated the innovative two-wheel driven business model of Viva Biotech that covers the CFS (Cash for Service) + EFS (Equity for Service). Along with the integration and expansion of the CFS business through the industrial chain and the continued growth of the EFS portfolio, Viva will continue adhering to their mission of becoming a cradle for innovative biote

Ying wuXueheng chengChen maoDavid xuFengmao huaViva bioinnovatorJianguo maCash for serviceEquity for serviceOnline investor dayViva biotechExecutive directorExecutive vice presidentDelin renBoard chairmanLanghua pharmaceutical